The most reliable clinical distinction is whether the scar extends beyond the original wound. Hypertrophic scars remain within the boundaries of the injury, usually become noticeable within 4–8 weeks after wound closure or trauma, and may gradually flatten. Keloids extend into previously uninjured skin, can arise months or years after minor trauma or appear spontaneously, and generally persist or continue enlarging.
A raised scar is not automatically a keloid. Map the lesion against the original wound, assess its timing and progression, and examine its firmness, symptoms, color, and surface before selecting laser, radiofrequency, microneedling, or surgical treatment.
Start With the Scar’s Relationship to the Wound
Hypertrophic scars stay within the injury
A hypertrophic scar is raised tissue that remains confined to the original wound or treatment area. It commonly follows surgery, burns, thermal injury, acne inflammation, or other trauma, particularly where the skin has been exposed to tension.
These scars may be linear, papular, or nodular. They are often firm and pink to red, and their prominence may decrease as remodeling progresses.
Keloids cross the original boundary
A keloid grows beyond the initial wound margin into surrounding, previously uninjured skin. This boundary behavior is the most useful practical discriminator during an aesthetic consultation.
The lesion may expand outward or laterally and can develop an irregular, bosselated, shiny surface. Keloids typically do not regress spontaneously and may continue evolving over time.
Confirm the original injury rather than relying on appearance alone
Patients may not remember the precise dimensions of a prior biopsy, injection, piercing, acne lesion, or energy-based treatment. Ask the patient to identify the original injury and compare it with the current lesion, photographs, treatment records, or surgical markings when available.
A lesion that appears “keloid-like” but remains strictly within the wound boundary is more consistent with hypertrophic scarring, although the distinction can be uncertain when the original injury is poorly defined.
Use Timing and Clinical Behavior
Hypertrophic scars usually appear relatively early
Hypertrophic scars commonly become evident within 4–8 weeks after wound closure or thermal trauma. They may become more raised or erythematous during the active remodeling phase before gradually softening or flattening.
This timing supports the diagnosis but does not establish it by itself. Early keloids can also resemble hypertrophic scars before their extension beyond the wound becomes obvious.
Keloids may have delayed onset
Keloids can develop long after the triggering injury, sometimes months or years later. They may also follow relatively minor trauma or occur without a clearly recalled injury.
A delayed, steadily enlarging lesion should therefore increase suspicion for keloid disease, especially when it crosses the original wound boundary.
Track progression over time
Document the lesion’s dimensions, color, elevation, symptoms, and pliability. Serial photographs and measurements are particularly useful when the diagnosis is not immediately clear.
A scar that progressively expands beyond the treated area is clinically concerning for keloid. A scar that remains localized and gradually becomes flatter is more consistent with hypertrophic scarring.
Compare the Physical Findings
Typical hypertrophic scar findings
Hypertrophic scars are commonly:
- Firm and raised
- Pink, red, or violaceous during active phases
- Linear, papular, or nodular
- Associated with high-tension wound sites
- Confined to the original injury
- Sometimes itchy or tender
- Capable of gradual improvement over time
Their clinical appearance can overlap with other raised lesions, so the boundary and time course remain essential.
Typical keloid findings
Keloids are commonly:
- Firm, shiny, and irregular or bosselated
- Pink, red, violaceous, or darker than surrounding skin
- Tender, pruritic, or painful in some patients
- Associated with visible telangiectasia in certain lesions
- Enlarging beyond the original wound
- Persistent or progressively expanding
Keloids are more frequently encountered in patients with darker skin phototypes and in areas such as the presternal chest, shoulders, and upper back, although they can occur at many sites.
Symptoms support but do not decide the diagnosis
Pain, itching, tenderness, and tightness can occur with both scar types. Symptoms may indicate activity or irritation, but they cannot substitute for assessment of the lesion’s boundaries and progression.
Evaluate Before an Energy-Based Procedure
Establish the risk history
Before fractional CO2 or Erbium laser, microneedling radiofrequency, surgical revision, or other controlled-injury procedures, ask about:
- Previous keloids or problematic scars
- Scarring after piercings, vaccinations, acne, burns, or surgery
- Family history of keloid formation
- Prior recurrence after excision or other treatment
- Lesion growth after previous procedures
- Current symptoms and rate of change
A history of keloid formation elsewhere is clinically important even when the current lesion is small or its boundary is difficult to assess.
Treat uncertain lesions conservatively
If the diagnosis is unclear, avoid assuming that a raised lesion is a routine hypertrophic scar. A planned ablative or mechanically traumatic procedure can worsen a keloid-prone response or create additional scar tissue.
Obtain an appropriate medical assessment before proceeding. If the lesion is atypical, rapidly changing, ulcerated, bleeding, unusually pigmented, or diagnostically uncertain, referral to a dermatologist or other qualified clinician is appropriate; biopsy may be needed to exclude alternative diagnoses.
Document a baseline
Record the original procedure or injury, date of onset, lesion dimensions, anatomical site, symptoms, and photographs. This creates a defensible baseline for treatment planning and helps distinguish genuine improvement from continued scar expansion.
Understand the Treatment Implications
Hypertrophic scars may be more suitable for remodeling strategies
When a scar is clearly hypertrophic, localized, stable, and clinically appropriate for treatment, options may include silicone gel or sheeting, pressure therapy, vascular-targeting modalities, fractional laser approaches, or other scar-remodeling strategies selected according to the lesion and patient.
Treatment should still be individualized. Erythema, thickness, pliability, skin phototype, prior response, and the risk of post-inflammatory hyperpigmentation all influence the protocol.
Keloids require a recurrence-focused plan
Keloid management is not simply a more aggressive version of hypertrophic-scar treatment. The central concern is controlling ongoing fibroproliferation and preventing recurrence.
Depending on the case, management may involve dermatologic or surgical assessment, silicone or compression therapy, intralesional medication, laser treatment as an adjunct, or combination protocols. Excision alone can carry a substantial recurrence risk and should not be treated as a routine first step.
Energy settings must follow diagnosis and tissue response
The scar category should influence whether treatment is appropriate, which modality is selected, treatment intervals, and how cautiously energy or needle depth is introduced. Parameters should not be chosen from a generic scar protocol without considering the possibility of keloid behavior.
The goal is controlled improvement without creating unnecessary additional injury. A cautious test area, staged treatment, and close review may be appropriate when treatment is undertaken by a suitably qualified practitioner.
Common Pitfalls to Avoid
Mistaking elevation for keloid formation
Both lesion types can be raised, firm, red, itchy, and cosmetically prominent. Elevation alone does not distinguish them; extension beyond the original wound is the defining practical clue.
Ignoring the original treatment footprint
After fractional laser or other procedures, pinpoint or patchy changes can make the original wound boundary difficult to interpret. Review treatment maps, photographs, and device records where possible instead of estimating the boundary from the current lesion alone.
Overrelying on onset timing
A scar that appears within 4–8 weeks is not automatically hypertrophic, and a delayed lesion is not automatically a keloid. Timing strengthens a clinical impression, but boundary behavior and serial progression carry greater diagnostic weight.
Treating a suspected keloid with repeated trauma
Ablation, microneedling, radiofrequency, or surgical manipulation can provoke further scar activity in susceptible patients. Repeated treatment without reassessing growth, symptoms, and recurrence risk can enlarge the problem rather than improve it.
Making unsupported predictions about response
Response varies with scar maturity, thickness, location, skin type, prior treatment, and biological tendency. Avoid promising a fixed percentage of improvement or assuming that a vascular laser alone will control a keloid.
Making the Right Choice for Your Goal
Use the clinical classification to determine whether the patient needs routine scar-remodeling assessment or specialist review before another procedure.
- If your primary focus is accurate diagnosis: Compare the lesion with the original wound boundary, then confirm the impression using onset, progression, symptoms, and physical characteristics.
- If your primary focus is procedural safety: Treat any lesion that extends beyond the wound, continues enlarging, or occurs in a patient with prior keloids as higher risk and obtain appropriate clinical assessment before applying additional controlled injury.
- If your primary focus is hypertrophic-scar management: Consider localized, staged approaches such as silicone, pressure, vascular treatment, or fractional remodeling when the scar is stable and the patient is an appropriate candidate.
- If your primary focus is keloid management: Use a recurrence-conscious, often multimodal plan with specialist input rather than relying on excision or energy treatment alone.
- If your primary focus is documentation: Photograph and measure the lesion consistently, record the original injury dimensions, and reassess progression before each treatment decision.
Boundary behavior is the central diagnostic clue, but safe management depends on combining it with timing, progression, morphology, risk history, and appropriate specialist evaluation.
Summary Table:
| Feature | Hypertrophic Scar | Keloid |
|---|---|---|
| Boundary | Stays within original wound | Extends beyond original wound |
| Onset | Usually 4-8 weeks after injury | Can develop months to years later |
| Progression | May gradually flatten | Tends to persist or enlarge |
| Symptoms | Itching, tenderness possible | Pain, itching, tenderness possible |
| Surface | Often smooth, may be linear/papular | Often irregular, shiny, bosselated |
For advanced scar management solutions, BELIS offers a comprehensive range of professional-grade aesthetic devices, including fractional CO2 lasers, microneedle RF, and vascular lasers, designed to help you treat hypertrophic scars and keloids with precision and safety. Our equipment is trusted by clinics and premium salons worldwide. Contact us today at [#ContactForm] to learn how BELIS can elevate your practice and deliver superior patient outcomes.